“We’re trying to make this something that you live with, and not something that you die of,” Dr. Nina Shah, a Multiple Myeloma Specialist at USCF, told SurvivorNet when discussing the outlook for people who are diagnosed with the disease.
The prognosis after a multiple myeloma diagnosis will vary from person to person, and will depend on DNA risk. People who are diagnosed with standard risk myeloma can expect to live at least 10 years. There are a handful of approved drugs and drug combinations to treat multiple myeloma, and maintenance therapy after treatment is also an extremely beneficial part of the process. “We have something called maintenance therapy which we know can make you live longer,” Dr. Shah said.
Read MoreLearn more about SurvivorNet's rigorous medical review process.